Wkh VRP dojrulwkp zdv lqwurgxfhg e| Nrkrqhq lq 4<;4 dqg kdv ehhq wkh irfxv ri d vl}hdeoh dprxqw ri dwwhqwlrq lq wkh vflhqwl f frppxqlw| vlqfh wkhq1 Qx0 phurxv dssolfdwlrqv kdyh ehhq sursrvhg +vhh Nrkr0 qhq ^4<<8` iru d uhsuhvhqwdwlyh olvw ri wkhp, dqg wkh wkhruhwlfdo surshuwlhv kdyh ehhq fduhixoo| vwxglhg +vhh Frwwuhoo/ Iruw ) Sdjëv ^4<<;` iru d uhylhz ri wkh hvwde0 olvkhg uhvxowv xs wr qrz,1 K...

BACKGROUND Variable domains of camelid heavy-chain antibodies, commonly named nanobodies, have high biotechnological potential. In view of their broad range of applications in research, diagnostics and therapy, engineering their stability is of particular interest. One important aspect is the improvement of thermostability, because it can have immediate effects on conformational stability, prot...

Poly(ADP-ribose) polymerase 1 (PARP1) is a key player in DNA repair, genomic stability and cell survival and it emerges as a highly relevant target for cancer therapies. To deepen our understanding of PARP biology and mechanisms of action of PARP1-targeting anti-cancer compounds, we generated a novel PARP1-affinity reagent, active both in vitro and in live cells. This PARP1-biosensor is based o...

In addition to its high affinity for antibody Fc domains, staphylococcal Protein A has been shown to bind certain Fab domains. We investigated this in order to develop a small, recombinant Protein A-binding alternative to immunoglobulin G (IgG) from nanobodies, single-domain antibodies derived from a camelid variant IgG's variable region. We engineered a nanobody with affinity solely for Protei...

iru dq| {> |> } # [/ wkhq g lv fdoohg d 80jhqhudol}hg glvwdqfh rq [ +vhh ^8`dqg ^6`,1 Erwk wkh svhxgr0 glvwdqfhv dqg wkh glvwdqfhv ghqhg rq oU. e| phdqv ri wkh rshudwlrq ./ wkh olqhdu rughu dqg h @ 3 duh h{dpsohv ri jhqhudol}hg glvwdqfhv1 Rq wkh rwkhu kdqg/ li 8 @ +V>>>v, lv d frppx0 wdwlyh rughuhg vhpljurxs zlwk d glvwlqjxlvkhg hoh0 phqw v/ d ixqfwlrq L = [ [ V lv fdoohg dq 80 lqglvwlqjxlvkdel...

Nanobodies are single chain antibodies that are uniquely produced in Camelidae, e.g. camels and llamas. They have the desirable features of small sizes (Mw < 14 kDa) and high affinities against antigens (Kd approximately nM), making them ideal as structural probes for biomedically relevant motifs both in vitro and in vivo. We have previously shown that nanobody binding to amyloidogenic human ly...

To complete the eradication of poliovirus and to protect unvaccinated people subsequently, the development of one or more antiviral drugs will be necessary. A set of five single-domain antibody fragments (variable parts of the heavy chain of a heavy-chain antibody [VHHs]) with an in vitro neutralizing activity against poliovirus type 1 was developed previously (B. Thys, L. Schotte, S. Muylderma...

The generation of Abs that recognize the native conformation of G protein-coupled receptors can be a challenging task because, like most multimembrane-spanning proteins, they are extremely difficult to purify as native protein. By combining genetic immunization, phage display, and biopanning, we identified two functional monovalent Abs (nanobodies) targeting ChemR23. The two nanobodies (CA4910 ...

Cytotoxic T‑lymphocyte antigen‑4 (CTLA‑4) is a critical negative regulator of immune responses. CTLA‑4 is rapidly upregulated following T‑cell activation, and then binds to B7 molecules with a higher affinity than CD28. CTLA‑4 may abolish the initiation of the responses of T cells by raising the threshold of signals required for full activation of T cells, and it also may terminate ongoing T-ce...